Deuterium Capital Management »

Mirati Therapeutics shares owned by Deuterium Capital Management

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Deuterium Capital Management from 13F filings

Historical chart of Deuterium Capital Management investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Deuterium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Deuterium Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $881k 15k 58.75

More positions owned by Deuterium Capital Management

Intuitive Surgical Com New (ISRG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Enovix Corp (ENVX)
Capri Holdings SHS (CPRI)
Imperial Pete Com New Call Option (IMPP)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Mirati Therapeutics
Sprott Fds Tr Uranium Miners E (URNM)
Global X Fds Global X Uranium (URA)
Neogames S A SHS (NGMS)
Uipath Cl A (PATH)
Invesco Exch Traded Fd Tr Ii S&p Smallcap Ene (PSCE)
Spdr Ser Tr S&p Homebuild (XHB)

View all positions for Deuterium Capital Management

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics